| 嘉和生物-B |
HongShan Capital Growth Fund V, L.P. |
增持 |
41836120 |
4183.61万股 |
0.08% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HSG Growth V Management, L.P. |
增持 |
41836120 |
4183.61万股 |
0.08% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HongShan Capital Growth Fund I, L.P. |
增持 |
92227856 |
9222.79万股 |
0.18% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HongShan Capital Growth Fund Management I, L.P. |
增持 |
105741632 |
10574.16万股 |
0.20% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HongShan Capital I, L.P. |
增持 |
30720853 |
3072.09万股 |
0.06% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HongShan Capital Management I, L.P. |
增持 |
39005650 |
3900.57万股 |
0.07% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
HSG Holding Limited |
增持 |
186583402 |
18658.34万股 |
0.36% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
SNP China Enterprises Limited |
增持 |
186583402 |
18658.34万股 |
0.36% |
好仓 |
2024-09-13 |
| 嘉和生物-B |
沈南鹏 |
增持 |
186583402 |
18658.34万股 |
0.36% |
好仓 |
2024-09-13 |
| 申港控股 |
Fully Fort Group Limited |
减持 |
-23115000 |
199.60万股 |
0.05% |
好仓 |
2024-09-13 |
| 申港控股 |
罗名译 |
减持 |
-23115000 |
199.60万股 |
0.05% |
好仓 |
2024-09-13 |
| 中国金石 |
郑永晖 |
增持 |
4767000 |
5639.19万股 |
0.26% |
好仓 |
2024-09-12 |
| 爱帝宫 |
Suntek Global Growth Fund SPC - Suntek Global Growth Fund Number One SP |
减持 |
-13276813 |
0.00万股 |
0.00% |
好仓 |
2024-09-12 |
| 博骏教育 |
Graymind Investments Limited |
增持 |
14032000 |
14421.20万股 |
0.16% |
好仓 |
2024-09-12 |
| 博骏教育 |
唐辉 |
增持 |
14032000 |
14421.20万股 |
0.16% |
好仓 |
2024-09-12 |
| 美兰空港 |
The Bank of New York Mellon Corporation |
增持 |
3827992 |
1186.73万股 |
0.05% |
好仓 |
2024-09-12 |
| 第四范式 |
戴文渊 |
减持 |
-37034192 |
14319.87万股 |
0.72% |
好仓 |
2024-09-12 |
| 第四范式 |
戴文渊 |
增持 |
37034192 |
3703.42万股 |
0.14% |
好仓 |
2024-09-12 |
| 第四范式 |
Tianjin Paradigm Chuqi Management Consulting Partnership (Limited Partnership) |
减持 |
-31981367 |
3198.14万股 |
0.16% |
好仓 |
2024-09-12 |
| 第四范式 |
Tianjin Paradigm Chuqi Management Consulting Partnership (Limited Partnership) |
增持 |
31981367 |
3198.14万股 |
0.12% |
好仓 |
2024-09-12 |
